Table 2

Results comparing the level of suPAR in different diseases

DiseaseP valueSMD95% CII2 (%)P heterogeneity
Primary FSGS vs secondary FSGS0.080.47−0.07 to 1.0169.70.01
Primary FSGS vs MCD<0.0011.721.27 to 2.2894.0<0.001
Primary FSGS vs MN<0.0010.880.50 to 1.2788.1<0.001
MCD and MN0.008−0.69−1.20 to 0.1889.8<0.001
  • FSGS, focal segmental glomerulosclerosis; MCD, minimal change disease; MN, membranous nephropathy; SMD, standard mean difference; suPAR, soluble urokinase plasminogen activated receptor.